Drugs in Dev.
Dermatology
Discovery
France 
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : EB005
Therapeutic Area : Dermatology
Study Phase : Discovery
Sponsor : GSK
Deal Size : $224.0 million
Deal Type : Collaboration
Eligo Bioscience Inks Deal with GSK Potentially Worth up to $224 Million
Details : Eligo will receive an upfront payment and R&D funding to advance EB005, until preclinical proof of concept. If GSK exercises its option, GSK and Eligo will enter into a license and collaboration agreement to jointly continue the development of EB005 in a...
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Undisclosed
January 11, 2021
Lead Product(s) : EB005
Therapeutic Area : Dermatology
Highest Development Status : Discovery
Sponsor : GSK
Deal Size : $224.0 million
Deal Type : Collaboration
